Background: The benefit of Thrombolytic Therapy (TT) for acute myocardial infarction is time sensitive. In Northern Ireland widespread availability of mobile coronary care units facilitates delivery of TT to heart attack victims. This region-wide prospective observational study assessed the efficacy of various methods of delivery of TT. Methods: All 15 acute hospitals providing acute coronary care in Northern Ireland participated and data were collected prospectively over six months on all patients admitted with acute myocardial infarction or who received TT. The information was analysed regarding appropriateness of TT, methods and timeliness ofdelivery of TT and mortality rates. Performance was measured against National Service Framework standards. Findings: Of 1638 patients with acute myocardial infarction 584 were considered eligible for TT and 494 (85%) received it, in addition to 18 patients without infarction. Of the 512 thrombolysed patients 282 (55%) were treated in hospital coronary care units, 131 (26%) were treated prehospital, 97 (19%) in accident and emergency departments, and two in general medical wards. Overall median call-to-needle time was 87 (7-1110) mins and this was shortest for pre-hospital treatment when 55% of call-to-needle times were s 60 mins. For patients treated in hospital median door-to-needle time was 46 (0-1065) mins and this was shortest when TT was administered by accident and emergency staff, when 65% of door-to-needle times were < 30 mins. In patients with ST elevation myocardial infarction TT was associated with lower mortality, especially when administered pre-hospital. Interpretation: NSF targets for TT are unlikely to be met in Northern Ireland without increasing pre-hospital delivery of TT and by improving collaboration between coronary care and accident and emergency staff with TT availability in accident and emergency departments.
INTRODUCTION
The introduction of thrombolytic therapy (TT) for acute myocardial infarction in the 1980's contributed greatly to improvement in both short'-5 and long term 6,7,8 survival rates. Early studies showed that the benefit achieved was inversely related to the delay between onset of symptoms and delivery of the thrombolytic drug." 3 5 9 Throughout Northern Ireland mobile coronary care became widely available following the pioneering work of Pantridge and Geddes in Belfast in 1966 10 and reduction of community mortality rate for myocardial infarction achieved by a mobile coronary care unit was clearly demonstrated in the pre-thrombolytic era."I With practitioners12 and by paramedics.13 '14 Numerous studies have demonstrated a superiority ofprimary angioplasty over TT in reducing mortality1I but it is unlikely to become widely available in the near future so TT continues to be the mainstay of reperfusion therapy. In order to assess the efficiency of delivery of TT in a region where mobile coronary care is widely available we conducted a prospective study of the timeliness ofadministration, appropriateness and effectiveness ofthis therapy throughout Northern Ireland over a six-month period.
PATIENTS AND METHODS
All fifteen hospitals providing acute coronary care in Northern Ireland (population 1.69 million) participated in the study and data were collected over six months from 1/04/01 to 30/09/01. Documentation was carried out by designated members of medical staff or senior nursing staff with the assistance of audit department staff. All patients admitted to hospital who received TT or who had a final diagnosis ofmyocardial infarction were included. Information relating to previous history, risk factors, indications and contraindications for TT, delay times for provision of coronary care and TT, sites where TT was administered, diagnostic tests and mortality rates was collected. A copy of the electrocardiograph (ECG) relevant to the decision for TT (usually the admission ECG) was retained to allow the accuracy of the diagnosis and appropriateness of the clinical decision to be checked by an independent assessor (C.W.) in consultation with the patient's consultant physician. The final diagnosis of myocardial infarction was at the discretion of the patient's consultant physician and depended on ECG changes and the results of cardiac enzymes and/or troponin levels as used in the local hospitals. The variable use of troponin levels throughout the hospitals led to a considerable variation in thresholds for diagnosis of non-ST elevation infarction. Eleven of the fifteen hospitals operated mobile coronary care units of various types; ten were staffed by a doctor, nurse and driver and one was nurse led. The nurse led unit did not routinely provide pre-hospital TT. All patients in Northern Ireland had access to a mobile coronary care unit at the request of themselves, their general practitioner or emergency ambulance personnel. Patients were admitted via mobile coronary care units, or via accident and emergency departments, or directly to hospital at the request of a general outcome making statistical comparison inappropriate. When TT was given pre-hospital or in accident and emergency departments mortality rates tended to be lower than when it was given in coronary care units (Table III) .
DISCUSSION
With the advent of TT for acute myocardial infarction it appeared that, within the UK, Northern Ireland was in a uniquely advantageous situation to achieve the maximum benefit because of widespread availability of mobile coronary care. This provided the means to deliver TT promptly to the coronary patient in addition to providing all other necessary acute treatment to stabilise the patient. 
